<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta name="Generator" content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:#1F497D;}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:#1F497D;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style></head><body lang="EN-US" link="blue" vlink="purple"><div class="WordSection1"><p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1f497d">Amani – This would have been nice information to add to the website… just sayin’.</span></p><p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1f497d"> </span></p><div><div style="border:none;border-top:solid #b5c4df 1.0pt;padding:3.0pt 0in 0in 0in"><p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> Felvtalk [mailto:<a href="mailto:felvtalk-bounces@felineleukemia.org">felvtalk-bounces@felineleukemia.org</a>] <b>On Behalf Of </b>Amani Oakley<br><b>Sent:</b> Wednesday, June 08, 2016 3:42 PM<br><b>To:</b> <a href="mailto:felvtalk@felineleukemia.org">felvtalk@felineleukemia.org</a><br><b>Subject:</b> Re: [Felvtalk] regarding: Raltegravir for Felv</span></p></div></div><p class="MsoNormal"> </p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d">Realissa,,</span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d">You can just do your own research on line. It is helpful to know the science behind it, and I have now found some articles online. This is a drug used in AIDS patients, and because the AIDS virus and FeLV are so similar, this is why they are looking to use it for FeLV. I have attached two scientific papers, but there are more. I only had time to find these two – from credible sources – to share for now.</span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d">I tried to attach them, but the annoying bounce back happened. (REALLY – please pay attention folks who host this group! This is very very time-consuming to always get these boucebacks and my attachments WEREN’T that large – 157 KB and 98 KB.)</span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d">Anyhow - the titles of the articles, if anyone wants to look them up yourselves, are:</span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d">Discovery of Drugs that Possess Activity Against Feline Leukemia Virus – Journal of General Virology (2012), 93, 900-905 and</span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d">Evaluation of the effect of short term treatment with the integrase inhibitor raltegravir (lsentress) on the course of progressive feline leukemia virus infection – Vet. Microbiol. 2015 Feb 25; 175(2-4)</span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d">Amani</span></p><p class="MsoNormal"><span lang="EN-CA" style="font-size:10.0pt;font-family:"Arial","sans-serif";color:#1f497d"> </span></p><p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> Felvtalk [<a href="mailto:felvtalk-bounces@felineleukemia.org">mailto:felvtalk-bounces@felineleukemia.org</a>] <b>On Behalf Of </b>Realissa Dekraunti<br><b>Sent:</b> June-08-16 9:43 AM<br><b>To:</b> <a href="mailto:felvtalk@felineleukemia.org">felvtalk@felineleukemia.org</a><br><b>Subject:</b> [Felvtalk] regarding: Raltegravir for Felv</span></p><p class="MsoNormal"><span lang="EN-CA"> </span></p><div><p class="MsoNormal"><span lang="EN-CA">the lady has not responded and has not seen my messages. I am desperately trying to get ahole of her. I don't know if it is appropriate to share her name here on this group? So, maybe you can all help me to get ahold of her? Her story is very inspiring </span></p></div></div></body></html>